InfantRisk Center

What InfantRisk Center does

InfantRisk Center is a research and clinical information service operating within Texas Tech University Health Sciences Center (TTUHSC), headquartered in Amarillo, Texas. The center is dedicated to medication safety during pregnancy and lactation, serving four primary constituencies: prescribing clinicians (physicians, pharmacists, nurse practitioners), breastfeeding mothers, pharmaceutical companies, and government agencies. Its core deliverable is the authoritative reference text "Hale's Medications and Mothers' Milk," now in its 22nd edition, which provides pharmacokinetic data, relative infant dose (RID) values, and clinical protocols for prescribing during lactation.

The center's technology stack is anchored by the Human Milk Biorepository, a research repository of human milk samples used for empirical drug transfer studies using LC-MS/MS analytical methodology. Services are delivered through multiple channels: a toll-free helpline (1-806-352-2519) staffed by retired registered nurses who consult with Dr. Thomas Hale, the MommyMeds mobile application for iOS and Android, community forums, and a website offering clinical and patient resources. The center has cumulatively answered over 160,000 clinician and parent calls, published 75+ peer-reviewed papers in indexed medical journals, and maintains 30+ years of continuous research output.

InfantRisk Center is not structured as a commercial revenue entity. It is funded through institutional support from TTUHSC and charitable benefactors including the Laura Bush Institute for Women's Health, Children's Miracle Network, David & Nona Payne Foundation, and Marshall Verne Ross Foundation. No product pricing is publicly disclosed, no funding rounds appear in the materials, and no commercial revenue mechanics are in place. The center is led by Dr. Thomas Hale as the principal authority and Dr. Kaytlin Krutsch as a key researcher, with a broader contributor base spanning clinical associates and published co-authors.

Name

InfantRisk Center

Legal name

InfantRisk Center

Website

https://infantrisk.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

InfantRisk Center is a TTUHSC-affiliated research center providing evidence-based medication safety guidance for lactation and pregnancy, serving clinicians, breastfeeding mothers, pharmaceutical companies, and government agencies through its authoritative reference text, helpline, and human milk biorepository.

Ownership category

akta.pro rank

Product category

Lactation Pharmacology Research

NAICS

Other Individual and Family Services (624190), Home Health Care Services (62161)

SIC

Services-Health Services (8000)

akta.pro primary industry

Lactation & Infant Feeding Telehealth (lactation consulting, pumping support) (HLALAHAE)

akta.pro secondary industries

Lactation, Postpartum & Perinatal Support Services (HLAFAJAN), Breastfeeding, Lactation & Infant Feeding Support (EDACAMAB)

Keywords

• Lactation pharmacology research
• Medication safety guidance
• Breastfeeding clinical resources
• Human milk biorepository
• Drug transfer studies

Headquarters

HQ city

Amarillo

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Research Funding and Benefactors: The center is funded through benefactors including Texas Tech University Health Sciences Center, Laura Bush Institute for Women's Health, Children's Miracle Network, David & Nona Payne Foundation, and Marshall Verne Ross Foundation. Revenue supports research operations, the helpline, and educational resources.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

The InfantRisk Center is a research and information service focused on medication safety during lactation and pregnancy. It maintains 'Hale's Medications and Mothers' Milk' (22nd edition), the standard reference text used by clinicians worldwide to determine medication compatibility with lactation. The center operates a toll-free helpline (1-806-352-2519) staffed by retired registered nurses who consult with Dr. Thomas Hale and has answered more than 160,000 clinician and parent calls. It also operates a Human Milk Biorepository that supports empirical drug-in-milk studies and provides the MommyMeds mobile app along with clinical and patient resources for prescribing healthcare providers and breastfeeding mothers.

Product overview

InfantRisk Center operates as the global authority in lactation pharmacology, offering a unified suite of research, reference, and consultation services. The core portfolio centers on Hale's Medications and Mothers' Milk (22nd edition), the industry-standard reference, supported by the InfantRisk Helpline staffed by registered nurses consulting with Dr. Thomas Hale. The organization provides the MommyMeds App for patient self-service, clinical resources for healthcare providers, and operates the InfantRisk Human Milk Biorepository for ongoing drug transfer research. These offerings interconnect to provide evidence-based medication safety guidance during breastfeeding and pregnancy.

Differentiator

Problem solved

Functional benefit

Brands

• MommyMeds: Mobile application to guide new and expecting moms with medication questions during breastfeeding and pregnancy

Products and services

• Hale's Medications and Mothers' Milk

Quantifiable outcome

• 160,000+ clinician and parent calls answered
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• KellyMom: A widely cited evidence-based breastfeeding information website run by a lactation consultant that translates research on medications, nutrition, and infant feeding for parents — overlapping directly with InfantRisk's patient-facing educational content and MommyMeds mission.
• MotherToBaby: A service of the non-profit Organization of Teratology Information Specialists (OTIS) that provides evidence-based information on medication and exposure safety during pregnancy and breastfeeding via helpline, fact sheets, and clinician resources — the closest functional peer to InfantRisk's lactation pharmacology mission.
• LactMed (U.S. National Library of Medicine): The NIH's free online database of drugs and dietary supplements that may pass into breast milk, with peer-reviewed summaries and RID data. LactMed is the most-cited free alternative reference to Hale's Medications and Mothers' Milk, serving the same clinician and breastfeeding-mother audience.
• La Leche League International: The largest global peer-support organization for breastfeeding mothers, providing evidence-based information and trained volunteer leaders who advise on medications and lactation. LLLI is a complementary (and partially overlapping) source of medication-in-breastfeeding guidance for mothers.
• e-lactancia: An independent online resource that grades medication compatibility with breastfeeding using evidence levels and provides guidance to both clinicians and mothers. It competes directly with InfantRisk's MommyMeds app and online resources, particularly in Spanish-speaking markets.

Broad incumbents

• WebMD: A leading general consumer health information platform with content on medication safety during pregnancy and breastfeeding. WebMD is a broad incumbent that overlaps with InfantRisk's patient-facing educational mission but lacks its depth in lactation pharmacology or its clinician-grade reference product.
• HealthyChildren.org (American Academy of Pediatrics): The AAP's parent-facing health information portal covering medication safety during breastfeeding among many pediatric topics. It serves the same parent audience but with a much broader scope and the institutional weight of the AAP, making it a broad incumbent rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/infantrisk
• Facebookfacebook.com/InfantRiskCenter
• LinkedInlinkedin.com/company/infant-risk-center

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InfantRisk Center